Group 6A: HR+ Breast Cancer; Biomarkers

Poster #1060: Genomic alterations (GA) in ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) patients (pts) with metastatic breast cancer (MBC): Co-occurrence and prevalence along treatment course.

Poster #1062: Comprehensive analysis of TROP2, PD-L1, stromal (s)TILs, and HER2 expression patterns in patients (pts) with metastatic HR+HER2- breast cancer.

Date

Jun 13 2024

Time

6:00 pm - 7:30 pm

Zoom Webinar

Category
REGISTER